Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Doxil Shortage Solution: FDA Chooses Middle Ground, Allows Import Of Unapproved Version

Executive Summary

FDA is allowing Sun Pharma Global FZE to import its unapproved liposomal version of doxorubicin, Lipodox, to alleviate a shortage, but has not yet given the drug full approval.

You may also be interested in...



Yesterday’s Solution; Tomorrow’s Problem

Two years ago, Sun Pharmaceuticals was a key part of FDA’s efforts in helping drug shortages; now FDA has banned imports from one of its plants.

Sun Pharmaceutical Aims To Keep Rivals In The Rearview Mirror

India’s Sun Pharmaceuticals says it is set to keep sales volumes growing in part through an aggressive acquisition strategy and a more diversified mix of products after third quarter profit more than quadruples.

Rx Imports Will Resolve Shortage Of Injectable Nutrition Drugs After Congressional Letter

Fresenius Kabi USA’s Norway plant is to supply the US with three injectable drugs used in total parenteral nutrition, primarily for treatment of premature infants; FDA has previously permitted importation of 11 other drugs that have been subject to shortages.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel